CWM
MRNA icon

Cranbrook Wealth Management’s Moderna MRNA Stock Holding History

Cranbrook Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4
Closed -$718 – 297
2022
Q4 		$718 Hold
4
– – ﹤0.01% 276
2022
Q3 		$0 Hold
4
– – ﹤0.01% 313
2022
Q2 		$1K Hold
4
– – ﹤0.01% 296
2022
Q1 		$1K Hold
4
– – ﹤0.01% 337
2021
Q4 		$1K Hold
4
– – ﹤0.01% 349
2021
Q3 		$2K Buy
+4
New +$1.48K ﹤0.01% 406

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cranbrook Wealth Management's MRNA Position: Q1 2023 in Review

Cranbrook Wealth Management sold out of Moderna (MRNA) in Q1 2023, closing a stake of 4 shares — an estimated $718 sold.

Cranbrook Wealth Management first reported a position in MRNA in Q3 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Cranbrook Wealth Management reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Cranbrook Wealth Management sold 4 Moderna shares in Q1 2023, an estimated $718.
  • Cranbrook Wealth Management first reported a position in Moderna in Q3 2021 and held it in 6 quarters.
  • Cranbrook Wealth Management's Moderna position peaked at $2K in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Cranbrook Wealth Management's 13F filing for Q1 2023, filed 20 Apr 2023.